World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
65393
World Ranking
9842
National Ranking
5061

Overview

Tim F. Greten is affiliated with the National Institutes of Health in the United States. Their research predominantly focuses on oncology with a strong emphasis on hepatology and immunology. Greten's work covers various aspects of cancer biology, particularly hepatocellular carcinoma (HCC), immune cell function, and cancer immunotherapy.

The main fields of study associated with Greten include Medicine and Biochemistry, Genetics, and Molecular Biology. Subfields of particular emphasis are Oncology, Immunology, Molecular Biology, Hepatology, and Cancer Research.

Greten's research has been published in several prominent venues. Frequent publication outlets include:

  • Journal of Clinical Oncology
  • Cancer Research
  • Regular and Young Investigator Award Abstracts
  • Journal of Hepatology
  • Journal for ImmunoTherapy of Cancer

The scientist's work addresses significant topics such as:

  • Cancer Immunotherapy and Biomarkers
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Immune Cell Function and Interaction
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Immune cells in cancer

Greten has collaborated extensively with several researchers. Frequent co-authors include:

  • Chi Ma
  • Benjamin Ruf
  • Xin Wei Wang
  • Firouzeh Korangy
  • Cecilia Monge

Selected recent papers that illustrate the scientist's research focus are:

  • "Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma," 2021, Nature Reviews Gastroenterology & Hepatology
  • "Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference," 2020, Hepatology
  • "Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma," 2021, Journal of Hepatology
  • "Gut microbiome in HCC - Mechanisms, diagnosis and therapy," 2020, Journal of Hepatology
  • "Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells," 2020, Cellular and Molecular Immunology

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

    Dung T. Le;Dung T. Le;Jennifer N. Durham;Jennifer N. Durham;Kellie N. Smith;Hao Wang

  • IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

    Florian R. Greten;Lars Eckmann;Tim F. Greten;Jin Mo Park

  • Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

  • EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

    Josep M. Llovet;Michel Ducreux;Riccardo Lencioni;Adrian M. Di Bisceglie

  • Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells

    Chi Ma;Miaojun Han;Bernd Heinrich;Qiong Fu

  • A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

    Bastian Hoechst;Lars A. Ormandy;Matthias Ballmaier;Frank Lehner

  • Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

    Lars A. Ormandy;Tina Hillemann;Heiner Wedemeyer;Michael P. Manns

  • Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.

    Austin G. Duffy;Susanna V. Ulahannan;Oxana Makorova-Rusher;Osama Rahma

  • NAFLD causes selective CD4 + T lymphocyte loss and promotes hepatocarcinogenesis

    Chi Ma;Aparna H. Kesarwala;Tobias Eggert;José Medina-Echeverz

  • Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor

    Bastian Hoechst;Torsten Voigtlaender;Lars Ormandy;Jaba Gamrekelashvili

  • Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

    Dung T. Le;Andrea Wang-Gillam;Vincent Picozzi;Tim F. Greten

  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

    Josep M. Llovet;Josep M. Llovet;Thierry De Baere;Thierry De Baere;Laura Kulik;Philipp K. Haber

  • Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression

    Tobias Eggert;Katharina Wolter;Juling Ji;Chi Ma

  • Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer

    Lichun Ma;Maria O. Hernandez;Yongmei Zhao;Monika Mehta

  • Myeloid derived suppressor cells in human diseases

    Tim F. Greten;Michael P. Manns;Firouzeh Korangy

  • Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

    Helmut Oettle;Hanno Riess;Jens M. Stieler;Gerhard Heil

  • Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial

    David Malka;Pascale Cervera;Stéphanie Foulon;Tanja Trarbach

  • Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.

    Lydia A. Haile;Reinhard von Wasielewski;Jaba Gamrekelashvili;Christine Krüger

  • Direct visualization of antigen-specific T cells: HTLV-1 Tax11–19- specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients

    Tim F. Greten;Jill E. Slansky;Ryuji Kubota;Samantha S. Soldan

Frequent Co-Authors

Michael P. Manns
Michael P. Manns Hannover Medical School
David E. Kleiner
David E. Kleiner National Institutes of Health
Bradford J. Wood
Bradford J. Wood National Institutes of Health
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
William D. Figg
William D. Figg National Institutes of Health
Volker Heinemann
Volker Heinemann Ludwig-Maximilians-Universität München
Jonathan P. Schneck
Jonathan P. Schneck Johns Hopkins University
Elizabeth M. Jaffee
Elizabeth M. Jaffee Johns Hopkins University
Katherine A. McGlynn
Katherine A. McGlynn National Institutes of Health
Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine in the USA opens doors to a variety of online degree paths beyond the traditional MD route. For registered nurses aiming to advance their practice, rn to np programs online offer a direct transition to roles such as nurse practitioner, expanding clinical responsibilities and earning potential.

Nutrition is another fast-growing healthcare field. Earning an online bs in nutrition can lead to careers in dietetics, public health, and wellness coaching—all in high demand as wellness becomes central to preventive care.

For those interested in healthcare leadership, cahme accredited mha online programs can equip you for management roles in hospitals, clinics, and health organizations, emphasizing skills in policy, finance, and operations.

Additionally, some nursing degrees now reduce clinical hour requirements. If flexibility is a priority, rn to bsn no clinical hours can provide an efficient way for working nurses to earn their Bachelor of Science in Nursing entirely online.

Best Scientists Citing Tim F. Greten

Trending Scientists